Tonight, Junaid Mian, RPh will be Moderating a panel on “Strategic Capital for Early Stage Biotechs Tackling Aging” at Daniel Dacey‘s event Biotech x Aging NYC: Building, Partnering, Investing with panelists Christopher R. Shepard, Greg Kubin, and Dylan V. Livingston.
This event will bring together scientists, startup operators, pharma professionals, and investors who are tackling age-related diseases to extend active life years. From neurodegeneration and immune aging to data-driven diagnostics and platform approaches, the field is advancing quickly, and the funding environment is shifting alongside it.
The evening will feature four panel discussions. The first will spotlight startup founders and scientists building novel approaches in aging-related disease. The second will bring together investors and pharmaceutical business development leaders to share how they evaluate opportunities in the space, where they are placing bets, and how they view the long-term potential of the field. Expect candid insights on what is working, what feels overhyped, and where the next breakthroughs may come from.
More information on the event can be found at: https://lu.ma/n1d6g87q